Leadership Team

Tony Aquila

Founder, Chairman & CEO

TONY AQUILA is Chairman and CEO of Solera Holdings, Inc. a company he founded in January 2005. As of March 9, 2015, Solera has a $3.6 billion-plus market capitalization, and a mission to bring about a digital evolution of risk and asset management for the automotive and property marketplace globally, including the P&C insurance industry.

Mr. Aquila has a proven track record building software businesses for the global automotive and insurance industries. He is a passionate and successful inventor who holds several patents and was named EY’s National Entrepreneur of the Year in 2013 in the Technology category. He strongly believes that everyone deserves a second chance and created the Solera LIFT – Life Is Full of Transformation – program to integrate an uncommon approach to giving and philanthropy into the company’s culture.

For more information about Tony … click here

Renato Giger

Chief Financial Officer

Renato Giger has been an employee of Solera since 2006.

Prior to joining Solera he served CSG as Chief Financial Officer of EMEA, Latin America. After the Company’s acquisition of CSG in 2006, he became the EMEA Chief Financial Officer, and was appointed Solera’s Global Corporate Controller in 2009.

Mr. Giger graduated with a Master’s degree in Science from the University of Berne (Switzerland).

Jason Brady

Chief Administrative Officer, General Counsel & Corporate Secretary

Prior to joining the Company in March 2008, Jason Brady provided legal consulting services to technology and entertainment organizations. Before that, he was Vice President, General Counsel and Corporate Secretary of biotechnology firm Xenogen Corporation. Brady represented Xenogen in its business defamation and patent infringement litigation with AntiCancer as well as its $80 million acquisition by Caliper Life Sciences, Inc.

As the Director of Legal Affairs for Abbott Diabetes Care, the diabetes testing device division of Abbott Laboratories, Mr. Brady oversaw domestic legal operations. He also worked as Director of Legal Affairs for TheraSense, Inc., a manufacturer of blood glucose monitoring systems. At TheraSense, Brady represented the company during its $131 million initial public offering and its $1.25 billion acquisition by Abbott Laboratories.

Prior to TheraSense, Brady was the General Counsel for Ensera, Inc., a provider of auto collision claims processing software, and Deputy General Counsel for AllAdvantage, a data management company.

At Ensera, he gained valuable insight into the software and services segment of the claims processing industry. During his tenure there he worked closely with Tony Aquila (Solera’s Founder, Chairman and CEO) to build the business as a member of the organization’s senior management team.

Mr. Brady started his career as an associate at Wilson Sonsini Goodrich & Rosati, P.C. He received a B.A. in History from the University of California Los Angeles, and his J.D. from Santa Clara University School of Law.